GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABL Bio Inc (XKRX:298380) » Definitions » Price-to-Funds-From-Operations

ABL Bio (XKRX:298380) Price-to-Funds-From-Operations : (As of Jun. 20, 2024)


View and export this data going back to 2018. Start your Free Trial

What is ABL Bio Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


ABL Bio (XKRX:298380) Business Description

Industry
Traded in Other Exchanges
N/A
Address
2nd Floor, 16 Daewangpangyo-Ro 712, Beon-Gil, Bundang-Gu, Gyeonggi-do, Seongnam-si, KOR, 13488
ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.